Cargando…

A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer’s disease

INTRODUCTION: Because of its genetic underpinnings and consistent age of onset within families, autosomal dominant Alzheimer’s disease (ADAD) provides a unique opportunity to conduct clinical trials of investigational agents as preventative or symptom-delaying treatments. The design of such trials m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grill, Joshua D., Bateman, Randall J., Buckles, Virginia, Oliver, Angela, Morris, John C., Masters, Colin L., Klunk, William E., Ringman, John M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511231/ https://www.ncbi.nlm.nih.gov/pubmed/26203303 http://dx.doi.org/10.1186/s13195-015-0135-0

Ejemplares similares

Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer’s disease
por: Müller, Stephan, et al.
Publicado: (2017)

Should persons with autosomal dominant AD be included in clinical trials?
por: Grill, Joshua D, et al.
Publicado: (2011)

Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
por: Bateman, Randall J, et al.
Publicado: (2011)

Neurological Manifestations of Autosomal Dominant Alzheimer’s Disease from the DIAN cohort and a meta-analysis
por: Tang, Mengxuan, et al.
Publicado: (2016)

Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer’s disease
por: Muenchhoff, Julia, et al.
Publicado: (2016)

Acculturation moderates cognitive performance in adults at risk of autosomal dominant Alzheimer's Disease.
por: Tureson, Kayla, et al.
Publicado: (2021)

Dominantly Inherited Alzheimer Network: facilitating research and clinical trials
por: Moulder, Krista L, et al.
Publicado: (2013)

Attitudes about involvement in hypothetical clinical trial protocols in Mexican and Mexican-American at risk for autosomal dominant Alzheimer’s disease
por: Zuno-Reyes, Angélica, et al.
Publicado: (2022)

Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group
por: Su, Yi, et al.
Publicado: (2016)

First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer’s disease: the Dominantly Inherited Alzheimer’s Network Study
por: O'Connor, Antoinette, et al.
Publicado: (2023)

Abnormal retinal capillary blood flow in autosomal dominant Alzheimer's disease
por: Singer, Maxwell B., et al.
Publicado: (2021)

Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group
por: Su, Yi, et al.
Publicado: (2016)

Discovery and validation of autosomal dominant Alzheimer’s disease mutations
por: Hsu, Simon, et al.
Publicado: (2018)

Attitudes toward clinical trials across the Alzheimer’s disease spectrum
por: Nuño, Michelle M., et al.
Publicado: (2017)

Ante‐ and postmortem tau in autosomal dominant and late‐onset Alzheimer’s disease
por: Chen, Charles D., et al.
Publicado: (2020)

White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease
por: Araque Caballero, Miguel Ángel, et al.
Publicado: (2018)

FMRI Complexity Correlates with Tau-PET and Cognitive Decline in Late-Onset and Autosomal Dominant Alzheimer’s Disease
por: Jann, Kay, et al.
Publicado: (2023)

Locus coeruleus integrity is related to tau burden and memory loss in autosomal-dominant Alzheimer’s disease
por: Dahl, Martin J., et al.
Publicado: (2022)

Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer’s disease brains
por: Novotny, Brenna C., et al.
Publicado: (2023)

Relationships between big‐five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's disease
por: Aschenbrenner, Andrew J., et al.
Publicado: (2020)

Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers
por: Brase, Logan, et al.
Publicado: (2023)

Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease
por: Dincer, Aylin, et al.
Publicado: (2020)

Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer’s disease
por: Vermunt, Lisa, et al.
Publicado: (2020)

White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer’s disease
por: Lee, Seonjoo, et al.
Publicado: (2018)

Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer’s disease
por: Franzmeier, Nicolai, et al.
Publicado: (2018)

Regional association of pCASL-MRI with FDG-PET and PiB-PET in people at risk for autosomal dominant Alzheimer's disease
por: Yan, Lirong, et al.
Publicado: (2017)

Circular RNA detection identifies circPSEN1 alterations in brain specific to autosomal dominant Alzheimer's disease
por: Chen, Hsiang-Han, et al.
Publicado: (2022)

Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease
por: Schultz, Stephanie A., et al.
Publicado: (2020)

Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer disease
por: Tu, Jiaxin Cindy, et al.
Publicado: (2023)

Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
por: Johnson, Erik C. B., et al.
Publicado: (2023)

Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [(18)F]flortaucipir study
por: O’Connor, Antoinette, et al.
Publicado: (2023)

Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies
por: Ringman, John M., et al.
Publicado: (2014)

Plasma biomarker profiles in autosomal dominant Alzheimer’s disease
por: Johansson, Charlotte, et al.
Publicado: (2023)

Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer disease: a longitudinal study
por: Gordon, Brian A., et al.
Publicado: (2018)

Diagnostic Value of Subjective Memory Complaints Assessed with a Single Item in Dominantly Inherited Alzheimer's Disease: Results of the DIAN Study
por: Laske, Christoph, et al.
Publicado: (2015)

Disclosure of individual research results at federally funded Alzheimer's Disease Research Centers
por: Roberts, J. Scott, et al.
Publicado: (2021)

CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer disease
por: Strain, Jeremy F., et al.
Publicado: (2022)

Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease
por: Vilaplana, Eduard, et al.
Publicado: (2020)

Dynamic Causal Modeling of Preclinical Autosomal-Dominant Alzheimer’s Disease
por: Penny, Will, et al.
Publicado: (2018)

Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer’s disease
por: Nicolas, Gaël, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3kq24jgdlo2pm4d5dt0cop7ks5